Title: Funding Programme


The CRG is Austria’s first funding programme in the field of non-commercial disease- and patient-oriented (translational), consortium-based clinical research.

on this page

The Call

Important dates

  • Call opens: September 22nd 2022
  • Short proposal submission deadline: November 17th 2022
  • Full proposal submission deadline: April 20th 2023 (upon invitation only)
  • On-site interviews: July 2023
  • CRG start: October 2023
  • Webinar with general information for applicants: October 4th 2022, 3.30 – 5.30 pm. Registration

    The webinar will be recorded and available on our website subsequently.

    Please send any questions you might have to xst@yot.np.ng. These will either be discussed during the webinar, or included in our Frequently Asked Questions section.

Funding and implementation

Scientific Remit

This first call for proposals for LBG Clinical Research Groups (CRG) aims to support larger collaborative research programmes with a strong focus on patient-oriented, medically important topics in the field of non-commercial clinic research. CRG supports the development of innovative research results in disease- or patient-oriented investigator-driven clinical studies with the possibility of integration of translational aspects. Simultaneously, the programme aims to promote high-quality scientific training of young clinical researchers within the framework of a clinical research group by means of research programme.

A coherent research programme should be presented that is structured into work packages or sub-projects, and meets the following criteria:

  • be innovative and of high quality in the field of disease and patient-oriented research, and develop diagnostic and/or therapeutic methods,
  • at least 50% of the proposed work must be carried out at medical universities/faculties,
  • present investigator-initiated clinical trials (phase I-III) or other non-commercial clinical studies in combination with clinical pilot or accompanying studies (observational, longitudinal studies, epidemiological studies, biobanking, biomarker studies, patient outcome studies, proof of concept studies, etc.),
  • meet the standards of good clinical practice,
  • demonstrate an interdisciplinary, synergistic collaborative attitude between clinical and non-clinical team members,
  • promote career development of young researchers/clinicians and address gender equality issues.


The main applicant of a CRG, the Lead Institution, must be an Austrian medical university/faculty with an affiliated university hospital.

The Lead Institution is asked to team up with one or more cooperation partners (e.g. public or private universities, universities of applied sciences, hospitals and/or non-profit academic research institutes) to form a consortium that must represent different disciplines.

CRG Composition

A CRG comprises of the following personnel:

  • one Mentor*,
  • one Head*,
  • one or more Sub-Project Manager(s), of which one or more Deputy Head(s)* have to be appointed, as well as
  • researchers and additional team members.

* employed at Lead Institution

Each CRG hosts between 5 and 15 directly funded individuals.

Funding Volume and Duration

  • Call budget: 24 Mio Euro (16 Mio Euro from Federal Ministry of Education, Science and Research (BMBWF) and 8 Mio Euro from Fonds Zukunft Österreich)
  • Funding: 0.5 – 1 Mio Euro per annum and max 90% of the total costs of the CRG, participating institutions must contribute min 10% of the total costs of the CRG in-kind
  • Duration: 4 + 4 years (after successful interim evaluation)

Selection Process

Two-stage call: Short proposals are evaluated by an international Scientific Expert Commission that will select applicants to submit full proposals. Full proposals will be peer-reviewed and applicants will subsequently attend on-site interviews with the Scientific Expert Commission.

Scientific Expert Commission

The Scientific Expert Committission provides strategic and operational support for program development and the review process. It comprises the following highly distinguished international scientific experts:

  • Chair: Prof. Liselotte Højgaard, University of Copenhagen, DK
  • Dr. Sophie Brouard, University Hospital of Nantes, FR
  • Prof. Gerhard Krönke, University Hospital Erlangen, DE
  • Prof. Roland Schwarz, University Hospital Köln, DE
  • Prof. Paul Matthews, Imperial College London, UK
  • Prof. Susanne Herold, University Hospital Gießen and Marburg, DE
  • Prof. Christian Jung, University Hospital Düsseldorf, DE
  • Prof. Philipp Kaufmann, Department of Nuclear Medicine, University Hospital Zürich, CH
  • Prof. Christoph Schindler, Hannover Medical School, DE



Forms to submit – Short Proposal stage

For reviewers – Short Proposal stage

Electronic submission platform

  • eCall (registration required)

Further Information and Contact

Program Management Ludwig Boltzmann Gesellschaft:

Neda Motamedi-Shad, MSc PhD

Mail: xst@yot.np.ng

Phone: +43 (0) 1 513 27 50-45

Technical questions regarding eCall (FFG):

Mail: sbreqrefreivpr@sst.ng

Phone: +43 (0) 5 7755-0

Frequently Asked Questions